420 related articles for article (PubMed ID: 9661084)
1. Urinary ovarian and gonadotropin hormone levels in premenopausal women with low bone mass.
Sowers M; Randolph JF; Crutchfield M; Jannausch ML; Shapiro B; Zhang B; La Pietra M
J Bone Miner Res; 1998 Jul; 13(7):1191-202. PubMed ID: 9661084
[TBL] [Abstract][Full Text] [Related]
2. Characterization of reproductive hormonal dynamics in the perimenopause.
Santoro N; Brown JR; Adel T; Skurnick JH
J Clin Endocrinol Metab; 1996 Apr; 81(4):1495-501. PubMed ID: 8636357
[TBL] [Abstract][Full Text] [Related]
3. Estrogen and peptide YY are associated with bone mineral density in premenopausal exercising women.
Scheid JL; Toombs RJ; Ducher G; Gibbs JC; Williams NI; De Souza MJ
Bone; 2011 Aug; 49(2):194-201. PubMed ID: 21549231
[TBL] [Abstract][Full Text] [Related]
4. Monitoring the menstrual cycle of humans and lowland gorillas based on urinary profiles of bioactive follicle-stimulating hormone and steroid metabolites.
Dahl KD; Czekala NM; Lim P; Hsueh AJ
J Clin Endocrinol Metab; 1987 Mar; 64(3):486-93. PubMed ID: 3102537
[TBL] [Abstract][Full Text] [Related]
5. The prediction and/or detection of ovulation by means of urinary steroid assays.
Cekan SZ; Beksac MS; Wang E; Shi S; Masironi B; Landgren BM; Diczfalusy E
Contraception; 1986 Apr; 33(4):327-45. PubMed ID: 3731775
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of ovulation by low-dose mifepristone (RU 486).
Ledger WL; Sweeting VM; Hillier H; Baird DT
Hum Reprod; 1992 Aug; 7(7):945-50. PubMed ID: 1331167
[TBL] [Abstract][Full Text] [Related]
7. Low bone mineral density in the early menopausal transition: role for ovulatory function.
Grewal J; Sowers MR; Randolph JF; Harlow SD; Lin X
J Clin Endocrinol Metab; 2006 Oct; 91(10):3780-5. PubMed ID: 16835283
[TBL] [Abstract][Full Text] [Related]
8. The association of endogenous hormone concentrations and bone mineral density measures in pre- and perimenopausal women of four ethnic groups: SWAN.
Sowers MR; Finkelstein JS; Ettinger B; Bondarenko I; Neer RM; Cauley JA; Sherman S; Greendale GA;
Osteoporos Int; 2003 Jan; 14(1):44-52. PubMed ID: 12577184
[TBL] [Abstract][Full Text] [Related]
9. The effect of exercise and estrogen on osteoprotegerin in premenopausal women.
West SL; Scheid JL; De Souza MJ
Bone; 2009 Jan; 44(1):137-44. PubMed ID: 18929691
[TBL] [Abstract][Full Text] [Related]
10. Bone mass and subtle abnormalities in ovulatory function in healthy women.
Waller K; Reim J; Fenster L; Swan SH; Brumback B; Windham GC; Lasley B; Ettinger B; Marcus R
J Clin Endocrinol Metab; 1996 Feb; 81(2):663-8. PubMed ID: 8636286
[TBL] [Abstract][Full Text] [Related]
11. The impact of intense training on endogenous estrogen and progesterone concentrations and bone mineral acquisition in adolescent rowers.
Morris FL; Payne WR; Wark JD
Osteoporos Int; 1999; 10(5):361-8. PubMed ID: 10591833
[TBL] [Abstract][Full Text] [Related]
12. Body size and ethnicity are associated with menstrual cycle alterations in women in the early menopausal transition: The Study of Women's Health across the Nation (SWAN) Daily Hormone Study.
Santoro N; Lasley B; McConnell D; Allsworth J; Crawford S; Gold EB; Finkelstein JS; Greendale GA; Kelsey J; Korenman S; Luborsky JL; Matthews K; Midgley R; Powell L; Sabatine J; Schocken M; Sowers MF; Weiss G
J Clin Endocrinol Metab; 2004 Jun; 89(6):2622-31. PubMed ID: 15181033
[TBL] [Abstract][Full Text] [Related]
13. Body composition and reproductive function exert unique influences on indices of bone health in exercising women.
Mallinson RJ; Williams NI; Hill BR; De Souza MJ
Bone; 2013 Sep; 56(1):91-100. PubMed ID: 23702387
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of ovarian activity by daily measurement of urinary excretion rates of oestrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part III: variability of normal menstrual cycle profiles.
Blackwell LF; Vigil P; Cooke DG; d'Arcangues C; Brown JB
Hum Reprod; 2013 Dec; 28(12):3306-15. PubMed ID: 24170744
[TBL] [Abstract][Full Text] [Related]
15. Female cancer survivors exposed to alkylating-agent chemotherapy have unique reproductive hormone profiles.
Johnson L; Sammel MD; Schanne A; Lechtenberg L; Prewitt M; Gracia C
Fertil Steril; 2016 Dec; 106(7):1793-1799.e2. PubMed ID: 27666565
[TBL] [Abstract][Full Text] [Related]
16. Urinary hormone levels during the natural menstrual cycle: the effect of age.
Hall Moran V; Leathard HL; Coley J
J Endocrinol; 2001 Jul; 170(1):157-64. PubMed ID: 11431148
[TBL] [Abstract][Full Text] [Related]
17. Relation of cardiovascular risk factors in women approaching menopause to menstrual cycle characteristics and reproductive hormones in the follicular and luteal phases.
Matthews KA; Santoro N; Lasley B; Chang Y; Crawford S; Pasternak RC; Sutton-Tyrrell K; Sowers M
J Clin Endocrinol Metab; 2006 May; 91(5):1789-95. PubMed ID: 16492698
[TBL] [Abstract][Full Text] [Related]
18. Postpartum return of ovarian activity in nonbreastfeeding women monitored by urinary assays.
Gray RH; Campbell OM; Zacur HA; Labbok MH; MacRae SL
J Clin Endocrinol Metab; 1987 Apr; 64(4):645-50. PubMed ID: 3818896
[TBL] [Abstract][Full Text] [Related]
19. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
Croxatto HB; Salvatierra AM; Romero C; Spitz IM
J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
[TBL] [Abstract][Full Text] [Related]
20. Plasma endothelin and LH-RH, LH, FSH, prolactin, progesterone, 17alpha-hydroxyprogesterone, estrone, 17beta-estradiol, delta4-androstenedione, testosterone, active renin, angiotensin-II and ANP levels in blood and LH, estrone and 17beta-estradiol and pregnanediol levels in urine of normal cycling women.
Usuki S; Kondoh K; Kubo T
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S421-7. PubMed ID: 11078439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
